Company news
Standard Biotools Inc. (NASDAQ:LAB) news
Standard Biotools Inc. news releases on 6ix. Latest, Apr 3, 2024: Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb…
Press releases — page 2
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research
April 2, 2024
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
March 17, 2024
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing
February 25, 2024
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 13, 2024
Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine
February 6, 2024
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
January 7, 2024
Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools
January 4, 2024
Standard BioTools Stockholders Approve Merger with SomaLogic
January 3, 2024
Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger
December 3, 2023
Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results
November 6, 2023
Standard BioTools Announces Conference Call and Webcast of Third Quarter 2023 Financial Results on November 7, 2023
October 24, 2023
Standard BioTools Reports Second Quarter 2023 Financial Results
August 7, 2023
Standard BioTools Announces Conference Call and Webcast for Second Quarter 2023 Financial Results
July 24, 2023
Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System
May 17, 2023
Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 14, 2023
Standard BioTools Reports First Quarter 2023 Financial Results
May 8, 2023
Standard BioTools Announces Conference Call and Webcast for First Quarter 2023 Financial Results
April 24, 2023
Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 19, 2023
Standard BioTools introduces the Hyperion XTi Imaging System, breaks barriers to power significant advancement in spatial biology
April 16, 2023
Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors
March 14, 2023
Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook
February 13, 2023
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results
January 30, 2023
Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
January 8, 2023
Standard BioTools Announces Appointment of Betsy Jensen as Chief Human Resources Officer
January 2, 2023
Standard BioTools Authorizes up to $20 Million of Share Repurchases
November 27, 2022
Standard BioTools Announces Third Quarter 2022 Financial Results
November 7, 2022
Standard BioTools and Visiopharm Announce Partnership for the Development of Complete Image Analysis Solutions to be Packaged With Hyperion and Hyperion+ Imaging Systems
November 6, 2022
Standard BioTools Announces Conference Call and Webcast of Third Quarter 2022 Financial Results
October 24, 2022
Standard BioTools Releases the X9 Real-Time PCR System, Its Most Productive and Flexible High-Capacity Genomics Platform
October 5, 2022
Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update
August 7, 2022
Standard BioTools Announces Conference Call and Webcast of Second Quarter 2022 Financial Results
July 24, 2022
Standard BioTools Announces First Quarter 2022 Financial Results
May 4, 2022
Standard BioTools Announces Conference Call and Webcast of First Quarter 2022 Financial Results
April 21, 2022
Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging
April 10, 2022
Fluidigm Announces Collaboration Agreement with Karolinska Institutet to Accelerate Customer Adoption of New CyTOF XT
September 27, 2021
Dr. Ana K. Stankovic, MD, PhD, Appointed to Fluidigm Board of Directors
December 14, 2020
Key Regulatory Body in India Grants Commercial License for Fluidigm Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay
November 23, 2020
New Collaboration with Bethyl Laboratories Expands Antibody Offerings for Hyperion Imaging System
June 16, 2020